Julie Brooks, PhD, is a Post-Doctoral Fellow within Pfizer’s Neuroscience Research Unit. Her current project focuses on optogenetic assessment of information integration in the ventral striatum. This work contributes towards an understanding of the brain circuitry underlying deficits in cognition associated with a variety of neurological disorders.

Dr. Brooks received her PhD from The Ohio State University where she examined how early developmental perturbations of the corticolimbic system alter the functional maturation of the cortex and contribute to cognitive deficits seen in schizophrenia.